Drug & Device

By Kate Greenwood
In Drug Pricing
Aug 27th, 2013
1 Comment
Here at Seton Hall Law, the halls are filled with the sounds of students again, which means our summer-long blog hiatus has come to an end.  We’re excited to get back to blogging at Health Reform Watch! As always, the blog will feature analysis and commentary from Seton Hall’s health law faculty and Recommended Reading […]...
By Nina Schuman
In Quality Improvement
May 31st, 2013
When patients undergo surgical or other medical procedures, they hope to receive optimal care provided by experienced physicians. They are rarely concerned about proper sterilization of surgical instruments and other medical equipment as it is likely assumed that the health care facility has applied this standard precaution. Unfortunately, however, not every medical ce...
By Kate Greenwood
In Health Law
May 14th, 2013
In his article Big Data and Pharmacovigilance: Using Health Information Exchanges to Revolutionize Drug Safety, which is forthcoming in the Iowa Law Review, Ryan Abbott argues that third parties, including academics, insurance companies, and rival drug companies, should be incentivized via an “administrative bounty proceeding” to analyze the large and rich datasets tha...
By Michael Ricciardelli
In Health Law
May 8th, 2013
By Frank Pasquale
In Health Reform
Mar 17th, 2013
Expect to keep hearing more talk about health care cost cutting, despite charts like this. It’s an idee fixe of the Wall Street/Washington corridor, and will only be implemented more vigorously over time.  So perhaps we should take stock of a few cost cutting initiatives. Medicare Part D, it seems, is coming way under its […]...